S2Medical
Logotype for S2Medical

S2Medical (S2M) investor relations material

S2Medical Q4 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for S2Medical
Q4 2025 earnings summary20 Feb, 2026

Executive summary

  • Net sales for the full year 2025 were 14.4 MSEK, down from 14.7 MSEK year-over-year, mainly due to reduced revenues from the Abena partnership as a result of lower costs in the collaboration.

  • Operating result for the year was -2.7 MSEK, compared to 4.8 MSEK in 2024, with the decline attributed to last year's positive impact from acquisition of shares in associates.

  • Net result for the year was -10.1 MSEK, compared to 4.8 MSEK in 2024, mainly due to a write-down of shares in the associate Eyracure.

  • Strategic focus was sharpened on core antimicrobial peptide (AMP) technology and advanced wound care, with increased founder ownership and new strategic partnerships.

Financial highlights

  • H2 2025 net sales: 7.5 MSEK (7.7 MSEK in H2 2024); full year: 14.4 MSEK (14.7 MSEK in 2024).

  • H2 2025 operating result: -2.1 MSEK (-2.4 MSEK in H2 2024); full year: -2.7 MSEK (4.8 MSEK in 2024).

  • H2 2025 net result: -10.2 MSEK (-2.4 MSEK in H2 2024); full year: -10.1 MSEK (4.8 MSEK in 2024).

  • Earnings per share for 2025: -0.01 SEK (0.01 SEK in 2024).

  • Cash and cash equivalents at year-end: 0.9 MSEK (1.0 MSEK at start of period).

Outlook and guidance

  • Focus will remain on commercializing AMP technology and expanding international partnerships.

  • Strengthened IP position and new distribution agreements are expected to support future growth.

AMP technology commercialization path
Eyracure's revised strategic importance
Key non-Epiprotect revenue streams
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.

Next S2Medical earnings date

Logotype for S2Medical
Q2 202621 Aug, 2026
S2Medical
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next S2Medical earnings date

Logotype for S2Medical
Q2 202621 Aug, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Explore our global coverage